| Zinaida Lyuboff, MD | |
|
135 Ocean Pkwy, Suite 1u, Brooklyn, NY 11218-2567 | |
| (718) 614-6167 | |
| (718) 769-0657 |
| Full Name | Zinaida Lyuboff |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 40 Years |
| Location | 135 Ocean Pkwy, Brooklyn, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003822628 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 214215 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| All Medical Care Llp | 5890685036 | 5 |
News Archive
Researchers from the University of Exeter in England have found that cancer patients are being mislead by many popular health web sites providing bogus information to peddle alternative medicinal treatments.
Researchers with the Department of Veterans Affairs (VA) and the Center for the Study of Traumatic Encephalopathy (CSTE) at Boston University School of Medicine have provided the first pathological evidence of a link between repeated head injuries—such as those experienced by athletes in contact sports such as boxing, football, and hockey—and a disease (chronic traumatic Encephalomyopathy) that resembles amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.
A yellowfin tuna product used to make dishes like sushi, ceviche and sashimi sold at restaurants and grocery stores has been connected with with an outbreak of salmonella that has sickened more than 100 people in 20 states and the District of Columbia, federal health authorities announced last Friday.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at The Parkinson's Institute and the Mayo Clinic have published new research findings in the journal Public Library of Science (PLoS). The new data show effective silencing of the alpha-synuclein gene with an RNAi therapeutic administered directly to the substantia nigra in the CNS of non-human primates.
Researchers and doctors at the Institute of Bioengineering and Nanotechnology (IBN), Singapore General Hospital (SGH) and National Cancer Centre Singapore (NCCS) have co-developed the first molecular test kit that can predict treatment and survival outcomes in kidney cancer patients. This breakthrough was recently reported in European Urology, the world's top urology journal.
› Verified 1 days ago
| Entity Name | All Medical Care Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316976426 PECOS PAC ID: 5890685036 Enrollment ID: O20040319000319 |
News Archive
Researchers from the University of Exeter in England have found that cancer patients are being mislead by many popular health web sites providing bogus information to peddle alternative medicinal treatments.
Researchers with the Department of Veterans Affairs (VA) and the Center for the Study of Traumatic Encephalopathy (CSTE) at Boston University School of Medicine have provided the first pathological evidence of a link between repeated head injuries—such as those experienced by athletes in contact sports such as boxing, football, and hockey—and a disease (chronic traumatic Encephalomyopathy) that resembles amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.
A yellowfin tuna product used to make dishes like sushi, ceviche and sashimi sold at restaurants and grocery stores has been connected with with an outbreak of salmonella that has sickened more than 100 people in 20 states and the District of Columbia, federal health authorities announced last Friday.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at The Parkinson's Institute and the Mayo Clinic have published new research findings in the journal Public Library of Science (PLoS). The new data show effective silencing of the alpha-synuclein gene with an RNAi therapeutic administered directly to the substantia nigra in the CNS of non-human primates.
Researchers and doctors at the Institute of Bioengineering and Nanotechnology (IBN), Singapore General Hospital (SGH) and National Cancer Centre Singapore (NCCS) have co-developed the first molecular test kit that can predict treatment and survival outcomes in kidney cancer patients. This breakthrough was recently reported in European Urology, the world's top urology journal.
› Verified 1 days ago
| Entity Name | New Horizon Medical P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659324192 PECOS PAC ID: 6800788811 Enrollment ID: O20040325001232 |
News Archive
Researchers from the University of Exeter in England have found that cancer patients are being mislead by many popular health web sites providing bogus information to peddle alternative medicinal treatments.
Researchers with the Department of Veterans Affairs (VA) and the Center for the Study of Traumatic Encephalopathy (CSTE) at Boston University School of Medicine have provided the first pathological evidence of a link between repeated head injuries—such as those experienced by athletes in contact sports such as boxing, football, and hockey—and a disease (chronic traumatic Encephalomyopathy) that resembles amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.
A yellowfin tuna product used to make dishes like sushi, ceviche and sashimi sold at restaurants and grocery stores has been connected with with an outbreak of salmonella that has sickened more than 100 people in 20 states and the District of Columbia, federal health authorities announced last Friday.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at The Parkinson's Institute and the Mayo Clinic have published new research findings in the journal Public Library of Science (PLoS). The new data show effective silencing of the alpha-synuclein gene with an RNAi therapeutic administered directly to the substantia nigra in the CNS of non-human primates.
Researchers and doctors at the Institute of Bioengineering and Nanotechnology (IBN), Singapore General Hospital (SGH) and National Cancer Centre Singapore (NCCS) have co-developed the first molecular test kit that can predict treatment and survival outcomes in kidney cancer patients. This breakthrough was recently reported in European Urology, the world's top urology journal.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Zinaida Lyuboff, MD 3411 Guider Ave Apt 6, Brooklyn, NY 11235-5235 Ph: (718) 333-2121 | Zinaida Lyuboff, MD 135 Ocean Pkwy, Suite 1u, Brooklyn, NY 11218-2567 Ph: (718) 614-6167 |
News Archive
Researchers from the University of Exeter in England have found that cancer patients are being mislead by many popular health web sites providing bogus information to peddle alternative medicinal treatments.
Researchers with the Department of Veterans Affairs (VA) and the Center for the Study of Traumatic Encephalopathy (CSTE) at Boston University School of Medicine have provided the first pathological evidence of a link between repeated head injuries—such as those experienced by athletes in contact sports such as boxing, football, and hockey—and a disease (chronic traumatic Encephalomyopathy) that resembles amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.
A yellowfin tuna product used to make dishes like sushi, ceviche and sashimi sold at restaurants and grocery stores has been connected with with an outbreak of salmonella that has sickened more than 100 people in 20 states and the District of Columbia, federal health authorities announced last Friday.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at The Parkinson's Institute and the Mayo Clinic have published new research findings in the journal Public Library of Science (PLoS). The new data show effective silencing of the alpha-synuclein gene with an RNAi therapeutic administered directly to the substantia nigra in the CNS of non-human primates.
Researchers and doctors at the Institute of Bioengineering and Nanotechnology (IBN), Singapore General Hospital (SGH) and National Cancer Centre Singapore (NCCS) have co-developed the first molecular test kit that can predict treatment and survival outcomes in kidney cancer patients. This breakthrough was recently reported in European Urology, the world's top urology journal.
› Verified 1 days ago
Mario Gustave, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 585 Schenectady Ave, Brooklyn, NY 11203 Phone: 718-604-5281 | |
Matthew Thrun-nowicki, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 150 55th St, Brooklyn, NY 11220 Phone: 718-630-7000 | |
Dr. Geraldine Orendain, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 760 Broadway, Woodhull Medical And Mental Health Center, Brooklyn, NY 11206 Phone: 718-963-5793 | |
Farokh Tarapore, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 1 Brookdale Plaza, Brookdale Univ Hosp & Med Ctr Dept Of Psychiatry, Brooklyn, NY 11212 Phone: 718-240-5678 Fax: 718-240-5986 | |
Amal Saha, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1545 Atlantic Ave, Brooklyn, NY 11213 Phone: 718-613-4000 | |
Jean Bien-aime, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 94-98 Manhattan Avenue, Cabs Health Center, Brooklyn, NY 11206 Phone: 718-388-0390 Fax: 718-486-5741 |